An opioid use disorder (OUD) initiative led by emergency department (ED) pharmacists contributed to a decrease in OUD-related ED visits at Boston Medical Center (BMC) over three years, even as such visits were on the rise nationwide, according to a study presented at the ASHP 2021 Midyear Clinical Meeting and Exhibition, held virtually.
The initiative focused on improving access to medications for OUD (MOUD)—as well as the opioid overdose reversal agent naloxone—and